BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1632 related articles for article (PubMed ID: 32580141)

  • 21. Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet.
    Lee MR; Park KI; Ma JY
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29295591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGFBP5 modulates lipid metabolism and insulin sensitivity through activating AMPK pathway in non-alcoholic fatty liver disease.
    Xiao Z; Chu Y; Qin W
    Life Sci; 2020 Sep; 256():117997. PubMed ID: 32585242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet-induced insulin-resistant mice.
    Zhang F; Hu Z; Li G; Huo S; Ma F; Cui A; Xue Y; Han Y; Gong Q; Gao J; Bian H; Meng Z; Wu H; Long G; Tan Y; Zhang Y; Lin X; Gao X; Xu A; Li Y
    Hepatology; 2018 Oct; 68(4):1361-1375. PubMed ID: 29637572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium Butyrate Supplementation Inhibits Hepatic Steatosis by Stimulating Liver Kinase B1 and Insulin-Induced Gene.
    Zhao ZH; Wang ZX; Zhou D; Han Y; Ma F; Hu Z; Xin FZ; Liu XL; Ren TY; Zhang F; Xue Y; Cui A; Liu Z; Bai J; Liu Y; Cai G; Su W; Dai X; Shen F; Pan Q; Li Y; Fan JG
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):857-871. PubMed ID: 33989817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimethylarginine Dimethylaminohydrolase 1 Protects Against High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice.
    Li T; Feng R; Zhao C; Wang Y; Wang J; Liu S; Cao J; Wang H; Wang T; Guo Y; Lu Z
    Antioxid Redox Signal; 2017 Apr; 26(11):598-609. PubMed ID: 27565538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
    Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
    J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
    Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
    Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.
    Sim WC; Lee W; Sim H; Lee KY; Jung SH; Choi YJ; Kim HY; Kang KW; Lee JY; Choi YJ; Kim SK; Jun DW; Kim W; Lee BH
    Metabolism; 2020 Jan; 102():154000. PubMed ID: 31678070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
    Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
    J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Hepassocin in Diabetic Patients with Nonalcoholic Fatty Liver Disease May Facilitate Increased Hepatic Lipid Accumulation.
    Abdelmoemen G; Khodeir SA; Zaki AN; Kassab M; Abou-Saif S; Abd-Elsalam S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):185-188. PubMed ID: 30009716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation.
    Schwerbel K; Kamitz A; Krahmer N; Hallahan N; Jähnert M; Gottmann P; Lebek S; Schallschmidt T; Arends D; Schumacher F; Kleuser B; Haltenhof T; Heyd F; Gancheva S; Broman KW; Roden M; Joost HG; Chadt A; Al-Hasani H; Vogel H; Jonas W; Schürmann A
    J Hepatol; 2020 Oct; 73(4):771-782. PubMed ID: 32376415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice.
    Devereux CJ; Bayliss J; Keenan SN; Montgomery MK; Watt MJ
    Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E187-E198. PubMed ID: 36629823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver sympathetic denervation reverses obesity-induced hepatic steatosis.
    Hurr C; Simonyan H; Morgan DA; Rahmouni K; Young CN
    J Physiol; 2019 Sep; 597(17):4565-4580. PubMed ID: 31278754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
    Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
    J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L; Kim JK; Bai Q; Zhang X; Kakiyama G; Min HK; Sanyal AJ; Pandak WM; Ren S
    Mol Pharmacol; 2013 Mar; 83(3):648-58. PubMed ID: 23258548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
    Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
    Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
    Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
    Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
    Kim JH; Jung DY; Nagappan A; Jung MH
    Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.